Nisa Investment Advisors’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$612 Hold
362
﹤0.01% 2833
2025
Q4
$717 Hold
362
﹤0.01% 2768
2025
Q3
$1.05K Hold
362
﹤0.01% 2737
2025
Q2
$655 Sell
362
-768
-68% -$1.37K ﹤0.01% 2828
2025
Q1
$1.7K Buy
1,130
+540
+92% +$1.36K ﹤0.01% 2509
2024
Q4
$1.39K Sell
590
-59
-9% -$1.04K ﹤0.01% 2592
2024
Q3
$19.1K Buy
649
+17
+3% +$392 ﹤0.01% 1921
2024
Q2
$7.8K Buy
632
+48
+8% +$1.01K ﹤0.01% 2206
2024
Q1
$11.8K Buy
584
+26
+5% +$599 ﹤0.01% 2010
2023
Q4
$12.6K Buy
558
+28
+5% +$592 ﹤0.01% 1989
2023
Q3
$8.82K Sell
530
-540
-50% -$10.7K ﹤0.01% 2196
2023
Q2
$26.2K Buy
1,070
+110
+11% +$2.65K ﹤0.01% 1992
2023
Q1
$23K Buy
960
+673
+234% +$18.6K ﹤0.01% 1969
2022
Q4
$8K Sell
287
-400
-58% -$14.4K ﹤0.01% 2246
2022
Q3
$25K Sell
687
-473
-41% -$12.8K ﹤0.01% 1993
2022
Q2
$33K Buy
1,160
+900
+346% +$22.7K ﹤0.01% 1883
2022
Q1
$10K Sell
260
-40
-13% -$1.7K ﹤0.01% 2206
2021
Q4
$13K Sell
300
-806
-73% -$42.3K ﹤0.01% 2001
2021
Q3
$69 Buy
1,106
+6
+0.5% +$501 ﹤0.01% 1848
2021
Q2
$94 Sell
1,100
-23,300
-95% -$1.25M ﹤0.01% 1726
2021
Q1
$1.1K Buy
24,400
+23,700
+3,386% +$932K 0.01% 915
2020
Q4
$5K Buy
+700
New +$6.25K ﹤0.01% 2268

Other funds holding FLNA

Nisa Investment Advisors's FLNA Position: Q1 2026 in Review

Nisa Investment Advisors held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 362 shares worth $612. The position accounts for ﹤0.01% of the portfolio, ranked #2833.

Nisa Investment Advisors first reported a position in FLNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $33K in Q2 2022. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Nisa Investment Advisors held 362 shares of Filana Therapeutics worth $612 as of Q1 2026.
  • Nisa Investment Advisors left its Filana Therapeutics share count unchanged in Q1 2026.
  • Filana Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2833 holding.
  • Nisa Investment Advisors first reported a position in Filana Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Nisa Investment Advisors's Filana Therapeutics position peaked at $33K in Q2 2022.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.